Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-010590
Filing Date
2017-11-14
Accepted
2017-11-14 14:54:28
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT cantabio10-qseptember2017.htm 10-Q 395600
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit311.htm EX-31.1 14098
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit312.htm EX-31.2 13992
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit321.htm EX-32.1 5300
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit322.htm EX-32.2 5636
  Complete submission text file 0001654954-17-010590.txt   1642248

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctbo-20170930.xml EX-101.INS 230700
7 XBRL TAXONOMY EXTENSION SCHEMA ctbo-20170930.xsd EX-101.SCH 26583
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctbo-20170930_cal.xml EX-101.CAL 12954
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctbo-20170930_def.xml EX-101.DEF 47217
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctbo-20170930_lab.xml EX-101.LAB 107004
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctbo-20170930_pre.xml EX-101.PRE 110423
Mailing Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54906 | Film No.: 171200754
SIC: 2834 Pharmaceutical Preparations